(Q45895363)

17 December 2017

title

Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer (English)

1 reference

17 December 2017

estrogen-receptor positive breast cancer

main subject

0 references

author name string

Hye Sung Won

1

1 reference

17 December 2017

Young Ae Kim

2

1 reference

17 December 2017

Jun Sang Lee

3

1 reference

17 December 2017

Eun Kyoung Jeon

4

1 reference

17 December 2017

Ho Jung An

5

1 reference

17 December 2017

Der Sheng Sun

6

1 reference

17 December 2017

Yoon Ho Ko

7

1 reference

17 December 2017

Jeong Soo Kim

8

1 reference

17 December 2017

publication date

31 July 2013

1 reference

17 December 2017

published in

Cancer Investigation

1 reference

17 December 2017

volume

31

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

516-521

1 reference

17 December 2017

Interleukin-6 in bone metastasis and cancer progression.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.826239

The soluble Interleukin 6 receptor: generation and role in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.826239

The IL-6/sIL-6R complex as a novel target for therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.826239

Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.826239

Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.826239

Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.826239

Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.826239

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.826239

Menopause and aging: changes in the immune system--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.826239

Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.826239

Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.826239

10.3109/07357907.2013.826239

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017